Nonetheless, the level of colonic IL-10 (an anti-inflammatory cytokine) in ghrelin-treated mice increased up to two times higher than normal mice without colitis, which suggested that IL-10 contributed to the therapeutic benefits of ghrelin on colonic inflammation. Here, GHRL is linked to colitis.